52results about How to "Few effect" patented technology

The present invention relates to pharmaceutical compositions of linagliptin, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.

The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.

The invention relates to the treatment or prevention of renal impairment and/or complications using a SGLT-2 inhibitor, for example in patients diagnosed with metabolic disorders and related conditions.

An image processing method and an image processor for drawing the movements of such linear objects as fur, hair, and grass of a turf being influenced by wind have not been proposed thus far. The present invention provides image processing method executed by an image processor for projecting and drawing linear objects viewed from view point on a two-dimensional plane when the view point, ground, and linear objects, of which one end of each linear object is fixed on the ground, are positioned in virtual three-dimensional space, comprising a drawing step of layering the cross-sections of linear objects created by cutting the plurality of linear objects at planes which are parallel with the ground for each of planes as semi-transparent layers, and a redrawing step of moving the semi-transparent layers in a predetermined direction after a predetermined time elapsed and redrawing the semi-transparent layer(s) on the two-dimensional plane.

The present invention provides transdermal drug delivery devices (i.e., patches) comprising O-desmethylvenlafaxine (ODV), a selective serotonin and norepinephrine re-uptake inhibitor, or a pharmaceutically acceptable salt thereof, which, among other, offer the advantage of eliminating or reducing the adverse side effects associated with the oral administration of ODV. Also provided are methods of preparing and using these transdermal delivery systems for the treatment of depression, anxiety disorders, vasomotor symptoms and pain.

In a method to determine an operating parameter of a shockwave source for the generation of a shockwave to disintegrate a calculus in a patient by a shockwave lithotripsy, a characteristic of the patient and/or of the calculus is determined before and/or during the shockwave lithotripsy and the operating parameter is automatically determined dependent on the characteristic. A device for determining an operating parameter of a shockwave source for the destruction of a calculus in a patient has an acquisition and control unit for determination and/or input of a characteristic of the patient and/or of the calculus, and for automatic determination of the operating parameter dependent on the characteristic.